Other strategy to target AML cells utilized CAR NK cells expressing the activating receptor NKG2D (NKX109), generated with the CAR vector NKG2-OX40-CD3ζ, and the mbIL-15. The gene discussed is KLRK1; the disease is acute myeloid leukemia.